[Cyclophosphamide in therapy of chronic progressive multiple sclerosis. Critical analysis of current studies].
Pette
M
M
Klinische Forschungsgruppe für Multiple Sklerose, Neurologische Universitätsklinik, Julius-Maximilians-Universität, Würzburg.
Hartung
H P
HP
Toyka
K V
KV
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000328:Adult; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy*; D009460:Neurologic Examination / Q000187:drug effects
D000305:Adrenal Cortex Hormones; D003520:Cyclophosphamide
Cyclophosphamid in der Therapie der chronisch-progredienten Multiplen Sklerose. Kritische Analyse der vorliegenden Studien.